ALEXANDRIA, Va., March 26 -- United States Patent no. 12,259,392, issued on March 25, was assigned to IsoPlexis Corp. (Branford, Conn.).
"System and methods for multiplexed analysis of cellular and other immunotherapeutics" was invented by Sean Mackay (New Haven, Conn.), Colin Ng (Branford, Conn.) and Emily Bettini (Waterbury, Conn.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are methods of identifying a secretome from a subject cell within a heterogeneous cell population when the subject cell contacts a target cell (e.g. a subject immune cell contacts a target cancer cell) or a stimulatory agent and methods of using the identified secretome to identify cells that are safe and efficacious for ce...